Pharmacological treatment of pain in multiple sclerosis

References

• Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain127(1–2), 34–41 (2007).
   Google Scholar
• Merskey H, Bogduk N. In: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd Edition). Report of the Task Force on Taxonomy of the International Association for the Study of Pain. IASP Press, Seattle, WA, USA (1994).
   Google Scholar
• Brichetto G, Messmer Uccelli M, Mancardi GL, Solaro C. Symptomatic medication use in multiple sclerosis. Mult. Scler.9(5), 458–460 (2003).
   PubMed Web of Science ®Google Scholar
• Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain79(1), 15–20 (1999).
   PubMed Web of Science ®Google Scholar
• Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch. Neurol.41, 1270–1272 (1984).
   PubMedGoogle Scholar
• Kassirer MR, Osterberg DH. Pain in chronic multiple sclerosis. J. Pain Symptom Management2, 95–97 (1987).
   PubMedGoogle Scholar
• Solaro C, Brichetto G, Amato MP et al. The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study. Neurology63, 919–921 (2004).
   PubMed Web of Science ®Google Scholar
• Paty DW, Ebers GC. Clinical features. In: Multiple Sclerosi. Paty DW, Erbs GC (Eds). F. A. Davis Company, PA, USA 135–191 (1998).
   Google Scholar
• Svendsen KB, Jensen TS, Overad K et al. Pain in patients with multiple sclerosis. Arch. Neurol.60, 1089–1094 (2003).
   PubMedGoogle Scholar
• Solaro C, Brichetto G, Battaglia MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol. Sci.25(6), 307–310 (2005).
   PubMed Web of Science ®Google Scholar
• Cianchetti C, Zuddas A, Randazzo AP, Perra L, Marrosu MG. Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology53(2), 433 (1999).
   PubMed Web of Science ®Google Scholar
• McCleane G. Lamotrigine can reduce neurogenic pain associated with multiple sclerosis. Clin. J. Pain14(3), 269–270 (1998).
   PubMed Web of Science ®Google Scholar
• Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult. Scler.3(4), 250–253 (1997).
   PubMed Web of Science ®Google Scholar
• Samkoff LM, Daras M, Tuchman AJ, Koppel BS. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology49(1), 304–345 (1997).
   PubMed Web of Science ®Google Scholar
• Herman RM, D’Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin. J. Pain8(4), 338–345 (1992).
   PubMed Web of Science ®Google Scholar
• Dahm PO, Nitescu PV, Appelgren LK, Curelaru II. Long-term intrathecal (i.t.) infusion of bupivacaine relieved intractable pain and spasticity in a patient with multiple sclerosis. Eur. J. Pain2(1), 81–85 (1998).
   PubMedGoogle Scholar
• Kalman S, Österberg A, Sörensen J, Boivie J, Bertler A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine. Eur. J. Pain6, 69–80 (2002).
   PubMed Web of Science ®Google Scholar
• Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J. Neurol. Sci.162(2), 162–168 (1999)
   PubMed Web of Science ®Google Scholar
• Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Br. Med. J.329(7460), 253 (2004).
   PubMed Web of Science ®Google Scholar
• Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology65(6), 812–819 (2005).
   PubMed Web of Science ®Google Scholar
• Zajicek J, Fox P, Sanders H et al. UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet362(9395), 1517–1526 (2003).
   PubMed Web of Science ®Google Scholar
• Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult. Scler.10(4), 434–441 (2004).
   PubMed Web of Science ®Google Scholar
• Parker HL. Trigeminal neuralgic pain associated with multiple sclerosis. Brain51, 46–62 (1928).
   Google Scholar
• Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology38(12), 1830–1834 (1988).
   PubMed Web of Science ®Google Scholar
• Österberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis – prevalence and clinical characteristics. Eur. J. Pain9(5), 531–542 (2005).
   PubMed Web of Science ®Google Scholar
• Jensen TS, Rasmussen P, Reske-Nielsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol. Scand.65, 182–189 (1982).
   PubMed Web of Science ®Google Scholar
• Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology45(7), 1294–1296 (1995).
   PubMed Web of Science ®Google Scholar
• Brisman R. Trigeminal neuralgia and multiple sclerosis. Arch. Neurol.44(4), 379–381 (1987).
   PubMedGoogle Scholar
• De Simone R, Marano E, Brescia Morra V et al. A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol. Sci.26, S150–S151 (2005).
   PubMed Web of Science ®Google Scholar
• Olafson RA, Rushton JG, Sayre GP. Trigeminal neuralgia in a patient with multiple sclerosis. An autopsy report. J. Neurosurg.24, 755–759 (1966).
   PubMed Web of Science ®Google Scholar
• Chakravorty BG. Association of trigeminal neuralgia with multiple sclerosis. Arch. Neurol.14(1), 95–99 (1966).
   PubMedGoogle Scholar
• Lazar ML, Kirkpatrick JB. Trigeminal neuralgia and multiple sclerosis: demonstration of the plaque in an operative case. Neurosurgery5, 711–717 (1979).
   PubMedGoogle Scholar
• Love S, Gradidge T, Coakham HB. Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol. Appl. Neurobiol.27, 238–244 (2001).
   PubMed Web of Science ®Google Scholar
• Broggi G, Ferroli P, Franzini A et al. Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis. Neurosurgery55(4), 830–838; discussion 838–839 (2004).
   PubMed Web of Science ®Google Scholar
• Cruccu G, Leandri M, Feliciani M, Manfredi M. Idiopathic and symptomatic trigeminal pain. J. Neurol. Neurosurg. Psychiatry53(12), 1034–1042 (1990).
   PubMed Web of Science ®Google Scholar
• Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology49(4), 1142–1144 (1997).
   PubMed Web of Science ®Google Scholar
• Meaney JFM, Watt JMG, Eldridge PR, Whitehouse GH, Wells JCD, Miles JB. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry59, 253–259 (1995).
   PubMed Web of Science ®Google Scholar
• Bergamaschi R, Romani A, Versino M et al. Usefulness of trigeminal somatosensory evoked potentials to detect subclinical trigeminal impairment in multiple sclerosis patients. Acta Neurol. Scand.89, 412–414 (1994).
   PubMedGoogle Scholar
• Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry29, 265–267 (1966).
   PubMed Web of Science ®Google Scholar
• Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch. Neurol.19, 129–136 (1968).
   PubMed Web of Science ®Google Scholar
• Nicol CF. A four year double blind study of tegretol in facial pain. Headache9, 54–57 (1969).
   PubMedGoogle Scholar
• Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. Br. Med. J.320(7242), 1113 (2000).
   PubMed Web of Science ®Google Scholar
• Linderoth B, Hakanson S. Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. Acta Neurol. Scand.80(4), 341–346 (1989).
   PubMedGoogle Scholar
• Kondziolka D, Lunsford LD, Bissonette DJ. Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can. J. Neurol. Sci.21(2), 137–140 (1994).
   PubMedGoogle Scholar
• Broggi G, Franzini A. Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain. J. Neurosurg.57(4), 483–486 (1982).
   PubMed Web of Science ®Google Scholar
• Berk C, Constantoyannis C, Honey CR. The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can. J. Neurol. Sci.30(3), 123–220 (2003).
   Google Scholar
• Rogers CL, Shetter AG, Ponce FA, Fiedler JA, Smith KA, Speiser BL. Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J. Neurosurg.97(Suppl. 5), 529–532 (2002).
   PubMedGoogle Scholar
• Huang E, Teh BS, Zeck O et al. Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients. Stereotact. Funct. Neurosurg.79(1), 44–50 (2002).
   PubMedGoogle Scholar
• Broggi G, Ferroli P, Franzini A, Pluderi M, La Mantia L, Milanese C. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet354(9193), 1878–1879 (1999).
   PubMedGoogle Scholar
• Resnick DK, Jannetta PJ, Lunsford LD, Bissonette DJ. Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis. Surg. Neurol.46(4), 358–361; discussion 361–362 (1996).
   PubMedGoogle Scholar
• Broggi G, Ferroli P, Franzini A, Servello D, Dones I. Microvascular decompression for trigeminal nevralgia: comments on a series of 250 cases, including 10 with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry68, 59–64 (2000).
   PubMed Web of Science ®Google Scholar
• Athanasiou TC, Patel NK, Renowden SA, Coakham HB. Some patients with multiple sclerosis have neurovascular compression causing their trigeminal neuralgia and can be treated effectively with MVD: report of five cases. Br. J. Neurosurg.19(6), 463–468 (2005).
   PubMed Web of Science ®Google Scholar
• Juniper RP, Glynn CJ. Association between proxysmal trigeminal neuralgia and atypical facial pain. Br. J. Oral Maxillofac. Surg.37, 444–447 (1999).
   PubMedGoogle Scholar
• Elrasheed AA, Worthington HV, Ariyaratnam S, Duxbury AJ. Opinions of UK specialists about terminology, diagnosis, and treatment of atypical facial pain: a survey. Br. J. Oral Maxillofac. Surg.42, 566–571 (2004).
   PubMedGoogle Scholar
• Fazzone HE, Lefton Dr, Kupersmith MJ. Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology110, 1646–1649 (2003).
   PubMed Web of Science ®Google Scholar
• Al-Araji AH, Oger J. Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult. Scler.11(4), 398–402 (2005).
   PubMed Web of Science ®Google Scholar
• Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology54(6), 1368–1370 (2000).
   PubMed Web of Science ®Google Scholar
• Ramirez-Lassepas M, Tulloch JW, Quinones MR, Snyder BD. Acute radicular pain as a presenting symptom in multiple sclerosis. Arch. Neurol.49(3), 255–258 (1992).
   PubMedGoogle Scholar
• Spissu A, Cannas A, Ferrigno P, Pelaghi AE, Spissu M. Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov. Disord.14(2), 331–335 (1999).
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult. Scler.6(3), 192–193 (2000).
   PubMed Web of Science ®Google Scholar
• Solaro C, Tanganelli P. Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study. J. Neurol. Neurosurg. Psychiatry75(2), 341 (2004).
   PubMedGoogle Scholar
• Restivo DA, Tinazzi M, Patti F, Palmeri A, Maimone D. Botulinum toxin treatment of painful tonic spasms in multiple sclerosis. Neurology61(5), 719–720 (2003).
   PubMed Web of Science ®Google Scholar
• Beiske AG, Pedersen ED, Czujko B, Myhr KM. Pain and sensory complaints in multiple sclerosis. Eur. J. Neurol.1, 479–482 (2004).
   Google Scholar
• Moulin D. Pain in central and peripheral demyelinating disorders. Neurol. Clin.16, 889–898 (1998).
   PubMedGoogle Scholar
• Thompson AJ. Symptomatic treatment in multiple sclerosis. Curr. Opin. Neurol.11, 305–309 (1998).
   PubMed Web of Science ®Google Scholar
• Al-Smadi J, Warke K, Wilson I et al. A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis. Clin. Rehabil.17(7), 742–749 (2003).
   PubMed Web of Science ®Google Scholar
• Warke K, Al Smadi J, Baxter D, Walsh DM, Lowe-Strong AS. Efficacy of transcutaneous electrical nerve stimulation (tens) for chronic low-back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial. Clin. J. Pain22(9), 812–819 (2006).
   PubMed Web of Science ®Google Scholar
• Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain. J. Neurosurg.67(2), 182–186 (1987).
   PubMed Web of Science ®Google Scholar
• Mirò J, Garcia-Moncò C, Leno C, Berciano J. Pelvic pain: an undescribed paroxysmal manifestation of multiple sclerosis. Pain32, 73–75 (1988).
   PubMedGoogle Scholar
• Vermote R, Ketalaer P, Carlton H. Pain in multiple sclerosis patients: a perspective using the McGill pain questionnaire. Clin. Neurol. Neurosurg.88, 87–93 (1986).
   PubMedGoogle Scholar
• Stenager E, Knutsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol. Scand.84, 197–200 (1991).
   PubMed Web of Science ®Google Scholar
• Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axon13(1), 26–28 (1991).
   PubMedGoogle Scholar
• Archibald CJ, McGrath PJ, Ritvo PG et al. Pain prevalence, severity and impact in a clinical sample of multiple sclerosis patients. Pain58, 89–93 (1994).
   PubMed Web of Science ®Google Scholar
• Indaco A, Iachetta C, Nappi C, Socci L, Carrieri PB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol.16, 97–102 (1994).
   PubMedGoogle Scholar
• Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Ital. J. Neurol. Sci.16(9), 629–632 (1995).
   PubMedGoogle Scholar
• Ehde DM, Gibbons LE, Chwastiak L, Bombardier CH, Sullivan MD, Kraft GH. Chronic pain in a large community sample of persons with multiple sclerosis. Mult. Scler.9(6), 605–611 (2003).
   PubMed Web of Science ®Google Scholar
• Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Mult. Scler.12, 629–638 (2006).
   Google Scholar
• Espir ML, Millac P. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J. Neurol. Neurosurg. Psychiatry33(4), 528–531 (1970).
   PubMed Web of Science ®Google Scholar
• Reder AT, Arnason BGW. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology45, 1097–1100 (1995).
   PubMed Web of Science ®Google Scholar
• Lunardi G, Leandri M, Albano C et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology48, 1714–1717 (1997).
   PubMed Web of Science ®Google Scholar
• Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology51(2), 611–614 (1998).
   PubMed Web of Science ®Google Scholar
• Solaro C, Lunardi GL, Capello E et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology51(2), 609–611 (1998).
   PubMed Web of Science ®Google Scholar
• Leandri M, Lunardi G, Inglese M et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J. Neurol.247(7), 556–558 (2000).
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur. Neurol.44(1), 45–48 (2000).
   PubMed Web of Science ®Google Scholar
• Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology55(10), 1587–1588 (2000).
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli MM, Brichetto G, Gasperini C, Mancardi GL. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J. Pain Symptom Manage.21(5), 367–368 (2001).
   PubMed Web of Science ®Google Scholar
• DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J. Neurol.250(5), 542–545 (2003).
   PubMed Web of Science ®Google Scholar